Russia’s sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses of the Sputnik V vaccine against COVID-19 per year in India, according to a statement on the Sputnik V Twitter account on November 27. (Read More)
Be the first to comment